A Phase 2 study of FNP-223 in Progressive Supranuclear Palsy (PSP)

Active, Not Recruiting Phase 2 NCT06355531

Study Description

A Study to Evaluate the Effectiveness and Safety of an Investigational Drug (FNP-223) in Slowing the Progression of Progressive Supranuclear Palsy

Study Details

Registry ID:: NCT06355531
Conditions:: Progressive Supranuclear Palsy
Phase:: Phase 2
Target Enrollment:: 241 participants
Start Date:: July 23, 2024
Age Range:: 50–80 years
Healthy Volunteers:: No

Study Locations (46 sites)

Hospital Universitario Virgen del Rocío
SevilleSpain, Spain
Hospital Universitario Virgen del Rocío
SevillaSpain, Spain
Hospital Universitari i Politècnic La Fe
ValenciaSpain, Spain
Campus Neurológico Senior - Torres Vedras
Torres VedrasPortugal, Portugal
Hospital Universitario Ramón y Cajal
MadridSpain, Spain
Hospital Universitario 12 de Octubre
MadridSpain, Spain
Hospital Clínic de Barcelona
BarcelonaSpain, Spain
Hospital Germans Trias i Pujol
BadalonaSpain, Spain
Hospital de Braga
BragaPortugal, Portugal
Hospital Universitario de Navarra
PamplonaSpain, Spain
Azienda Ospedaliera Universitaria San Giovanni di Dio Ruggi d'Aragona
SalernoItaly, Italy
Hospital Universitario Cruces
BarakaldoSpain, Spain
Hôpital Pierre-Paul Riquet
ToulouseFrance, France
Hôpital de la Timone
MarseilleFrance, France
L'Hôpital Universitaire Carémeau
NîmesFrance, France
Complejo Hospitalario Universitario A Coruña
A CoruñaSpain, Spain
Groupe Hospitalier Pellegrin
BordeauxFrance, France
Azienda Ospedaliero-Universitaria Pisana
PisaItaly, Italy
IRCCS Istituto Delle Scienze Neurologiche di Bologna
BolognaItaly, Italy
Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) - San Raffaele Pisana
RomaItaly, Italy
Azienda Ospedale Università di Padova
PaduaItaly, Italy
Azienda Ospedale Università di Padova
PadovaItaly, Italy
Hôpital Universitaire Pitié Salpêtrière
ParisFrance, France
Ludwig-Maximilians-Universität München (LMU)
MunichGermany, Germany
Pécsi Tudományegyetem Általános Orvostudományi Kar
PécsHungary, Hungary
University Hospital Southampton
SouthamptonUnited Kingdom, United Kingdom
University College London Hospitals
LondonUnited Kingdom, United Kingdom
Universitätsklinikum Düsseldorf
DüsseldorfGermany, Germany
University of Cambridge
CambridgeUnited Kingdom, United Kingdom
Universitätsklinikum Leipzig
LeipzigGermany, Germany
Neurologia Śląska Centrum Medyczne
KatowicePoland, Poland
Neurologisches Fachkrankenhaus für Bewegungsstörungen/Parkinson
BeelitzGermany, Germany
Newcastle Upon Tyne Hospitals
NewcastleUnited Kingdom, United Kingdom
Mazowiecki Szpital Bródnowski w Warszawie
WarsawPoland, Poland
Massachusetts General Hospital
Boston, MassachusettsUnited States, United States
University of Miami Miller School of Medicine
Miami, FloridaUnited States, United States
Columbia University Irving Medical Center
New York, New YorkUnited States, United States
Robert & John M. Bendheim Parkinson and Movement Disorders Center at Mount Sinai
New York, New YorkUnited States, United States
Duke Neurology
Durham, North CarolinaUnited States, United States
Augusta University
Augusta, GeorgiaUnited States, United States
Quest Research Institute
Farmington Hills, MichiganUnited States, United States
Vanderbilt University Medical Center
Nashville, TennesseeUnited States, United States
Central Texas Neurology Consultants
Round Rock, TexasUnited States, United States
Rocky Mountain Movement Disorders Center
Denver, ColoradoUnited States, United States
The Neurology Center of Southern California - Carlsbad
Carlsbad, CaliforniaUnited States, United States
UCSF Weill Institute for Neurosciences
San Francisco, CaliforniaUnited States, United States

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.

View full study details and check eligibility →